Principal Financial Group Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$144.95 - $152.29 $638,939 - $671,294	-4,408 Reduced 21.18%	16,402 $2.48 Million
Q2 2022 Aug 10, 2022	SELL	$83.14 - $145.99 $395,912 - $695,204	-4,762 Reduced 18.62%	20,810 $3.03 Million
Q1 2022 May 09, 2022	SELL	$110.08 - $142.92 $618,869 - $803,496	-5,622 Reduced 18.02%	25,572 $3.03 Million
Q4 2021 Feb 09, 2022	SELL	$99.73 - $148.48 $356,634 - $530,964	-3,576 Reduced 10.28%	31,194 $4.3 Million
Q3 2021 Nov 09, 2021	BUY	$98.85 - $138.91 $1.25 Million - $1.75 Million	12,628 Added 57.03%	34,770 $4.83 Million
Q2 2021 Aug 10, 2021	SELL	$65.78 - $105.02 $10.9 Million - $17.4 Million	-165,728 Reduced 88.21%	22,142 $2.15 Million
Q1 2021 May 10, 2021	BUY	$64.07 - $91.75 $10.2 Million - $14.5 Million	158,523 Added 540.17%	187,870 $12.8 Million
Q4 2020 Feb 08, 2021	BUY	$65.07 - $98.24 $282,338 - $426,263	4,339 Added 17.35%	29,347 $2.52 Million
Q3 2020 Nov 06, 2020	SELL	$59.04 - $77.95 $5,136 - $6,781	-87 Reduced 0.35%	25,008 $1.63 Million
Q2 2020 Aug 05, 2020	BUY	$29.01 - $74.23 $494,214 - $1.26 Million	17,036 Added 211.39%	25,095 $1.84 Million
Q1 2020 May 12, 2020	SELL	$27.51 - $57.29 $127,371 - $265,252	-4,630 Reduced 36.49%	8,059 $274,000
Q4 2019 Feb 05, 2020	BUY	$40.86 - $57.65 $62,965 - $88,838	1,541 Added 13.82%	12,689 $691,000
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $194,974 - $258,035	5,216 Added 87.93%	11,148 $465,000
Q2 2019 Aug 12, 2019	BUY	$39.79 - $67.01 $835 - $1,407	21 Added 0.36%	5,932 $260,000
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $12,806 - $19,770	371 Added 6.7%	5,911 $304,000
Q4 2018 Feb 14, 2019	SELL	$29.75 - $42.9 $2,945 - $4,247	-99 Reduced 1.76%	5,540 $205,000
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $9,050 - $11,868	276 Added 5.15%	5,639 $212,000
Q2 2018 Aug 13, 2018	BUY	$23.62 - $42.29 $126,674 - $226,801	5,363 New	5,363 $0

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account